Search - tctmd.com

Displaying 61 - 76 of 76

Sort: Relevancy | Date

News Daily News

Meta 分析表明 Watchman 依旧不逊于华法林，患者结局良好及安全

Yael L. Maxwell

June 17, 2015

Presentation TVT 2015

Case Presentation: LAA Occlusion and TAVR

Presenter: Howard C. Herrmann, Alec S. Vahanian, Brij Maini

June 04, 2015

News Daily News

Registry Data Suggest Protection Up to 2 Years With LAA Closure

Caitlin E. Cox

January 28, 2015

News Daily News

Hospital Volume Linked to More Favorable LAA Closure Outcomes

Todd Neale

December 11, 2014

News Daily News

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

Caitlin E. Cox

November 19, 2014

Presentation TCT 2014

Fundamental Knowledge: Left Atrial Appendage Anatomy, Function, and Relational Pathology

Presenter: Marsha Holton, John R. Zimmerman, Brij Maini

September 13, 2014

Presentation LAA 2014

RT 3D ICE & Future Imaging

Presenter: Brijeshwar Maini

July 19, 2014

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Conference News EuroPCR 2014

Benefit of LAA Closure Becomes Most Evident After 1 Year

Caitlin E. Cox

May 23, 2014

News Daily News

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

Yael L. Maxwell

May 17, 2013

News Daily News

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

Jason Kahn

February 28, 2013

News Daily News

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

Caitlin E. Cox

January 30, 2013

News Daily News

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

September 27, 2012

News Daily News

Left Atrial Appendage Morphology May Help Predict Stroke Risk in A-fib Patients

July 31, 2012

News Daily News

Lack of Complete Seal with Watchman Device Common, But No Cause for Alarm

Jason Kahn

March 05, 2012

News Daily News

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

Caitlin E. Cox

January 20, 2011

Advertisement

Meta 分析表明 Watchman 依旧不逊于华法林，患者结局良好及安全

Case Presentation: LAA Occlusion and TAVR

Registry Data Suggest Protection Up to 2 Years With LAA Closure

Hospital Volume Linked to More Favorable LAA Closure Outcomes

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

Fundamental Knowledge: Left Atrial Appendage Anatomy, Function, and Relational Pathology

RT 3D ICE & Future Imaging

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

Benefit of LAA Closure Becomes Most Evident After 1 Year

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

Left Atrial Appendage Morphology May Help Predict Stroke Risk in A-fib Patients

Lack of Complete Seal with Watchman Device Common, But No Cause for Alarm

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content